Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2010 by Lipid Therapeutics GmbH.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Lipid Therapeutics GmbH
ClinicalTrials.gov Identifier:
NCT01011322
First received: November 10, 2009
Last updated: November 15, 2011
Last verified: August 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2012
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
No publications provided by Lipid Therapeutics GmbH

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):